Field Trip Health Ltd. will participate in the next conferences in December 2021

TORONTO, 01 Dec. 2021 (GLOBE NEWSWIRE) – Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (“Field Trip”), a global leader in the development and delivery of psychedelic therapies, today announced that management will present at the 2nd conference HC Wainwright’s annual conference on psychedelics and Stifel’s 2nd annual conference on the future of healthcare in December.

2nd Annual HC Wainwright Psychedelics Conference
Field Trip Co-Founder and CEO Joseph Del Moral and Chief Scientific Officer Dr Nathan Bryson will be giving a live presentation at HC Wainwright’s 2nd Annual Psychedelics Conference on Monday, December 6.e. A recording of the Field Trip presentation will be available upon request from Monday, December 6e at 7:00 a.m. Eastern Time, via the following link: https://journey.ct.events/view/c5617d9d-c81a-4cc7-b81d-754d93bb10be.

2nd annual Stifel conference on the future of healthcare
Field Trip Co-Founder and Executive Chairman Ronan Levy and Scientific Director Dr Nathan Bryson will give a live presentation at the Stifel Virtual Healthcare conference on Wednesday, December 8.e at 12:30 p.m. Eastern Time. To view the presentation, please register via this link: https://wsw.com/webcast/stifel62/register.aspx?conf=stifel62&page=ftrp&url=https://wsw.com/webcast/stifel62/ftrp/2112420.

Recordings of the presentations will be available on the Field Trip Investor Relations website via the links above for 90 days.

The Field Trip management team will be available for one-on-one meetings throughout the duration of the conferences. To schedule a meeting with the Field Trip leadership team, please contact KCSA Strategic Communications at [email protected]

About Field Trip Health Ltd.

Field Trip is a global leader in the development and delivery of psychedelic therapies. With our Field Trip Discovery division leading the development of the next generation of psychedelic molecules and leading advanced research in herbal psychedelics and our Field Trip Health division building psychedelic therapy centers in North America and Europe as well as digital and technological tools that will enable on a massive scale, we are helping those in need with a simple, evidence-based way to heal and scale up engagement with the world.

Learn more about https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.

Follow us on Twitter and Instagram: @fieldtriphealth.

To receive company updates on Field Trip and to be added to the email distribution list, please subscribe here.

Caution regarding forward-looking information

This press release contains forward-looking information (within the meaning of Canadian securities laws and the US Private Securities Litigation Reform Act of 1995) regarding Field Trip and its activities. Often, but not always, forward-looking information can be identified by the use of words such as “expect”, “intend”, “anticipate”, “believe” or variations (including negative variations) of such words and expressions, or state that certain actions, events or results “may”, “could”, “would” or “will” be undertaken, occur or be achieved. These statements are based on the current expectations and views of future events of the management of Field Trip and are based on assumptions and subject to risks and uncertainties. Although the management of Field Trip believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances described in this press release may not occur and could differ materially due to known and unknown risk factors and uncertainties affecting the companies, including those set forth in the Company’s Annual Information Form and others. market conditions, economics, management’s ability to manage and operate the business and the stock markets in general. Although Field Trip has attempted to identify material factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or or results differ from those anticipated, estimated or intended. Therefore, readers should not place undue reliance on forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Field Trip assumes no obligation to publicly update or revise any forward-looking statements, whatsoever. either as a result of new information, future events, or otherwise. Additional information relating to Field Trip, including its Annual Information Form, can be found on the SEDAR website at www.sedar.com and in the EDGAR section of the SEC website at www.sec .gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

Neither the Toronto Stock Exchange nor its regulatory services provider has endorsed the contents of this release or accepts responsibility for the adequacy or accuracy of this release.

CONTACTS:

Media contacts:
Rachel moskowitz
Fall communications
202-276-7881
[email protected]

Nick Opich / McKenna Miller
KCSA strategic communication
212-896-1206 / 347-487-6197
[email protected]

Investor contacts:
Kathleen Heaney / Tim Regan
KCSA strategic communication
[email protected]

SOURCE Field Trip Health Ltd.

About Stephen Arrington

Check Also

SEC football 2022: 5 conference games to watch

The college football season is approaching and excitement is building for some major SEC matchups …